Transversalis Fascia Plane Block Versus Intrathecal Morphine for Postoperative Analgesia in Total Abdominal Hysterectomy

Tanta University

Status: Enrolling

Conditions: Postoperative Analgesia; Transversalis Fascia Plane Block; Intrathecal Morphine; Total Abdominal Hysterectomy

Treatments: Drug: Morphine; Other: Transversalis fascia plane block

Study type: Interventional

Funder types: Other

Identifiers

NCT07201272

36264PR1337/8/25

Details and patient eligibility

About

This study aims to compare the ultrasound-guided transversalis fascia plane (TFP) block and intrathecal morphine for postoperative analgesia in patients undergoing total abdominal hysterectomy (TAH).

Full description

Total abdominal hysterectomy (TAH) is a commonly performed major surgical procedure that results in substantial postoperative pain and discomfort. Postoperative pain, if not treated promptly, can impair the patient's ability to ambulate which may lead to adverse effects such as thromboembolism, myocardial ischemia, and arrhythmia.

Intrathecal opioids are synergistic with local anesthetics and intensify the sensory block without increasing the sympathetic block. Morphine, which is relatively less hydrophobic than other opioids, has a longer residence time in the cerebrospinal fluid and therefore may reach rostral sites over a longer period than other opioids.

Ultrasound-guided interfascial plane blocks are often used in multimodal analgesia regimens. Local anaesthetic injection into the transversalis fascia plane (TFP) anesthetizes the proximal branches of T12 and L1 which targeted in the plane between the transversus abdominis muscle and the transversalis fascia.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age from 18 to 65 years.
• American Society of Anesthesiology (ASA) physical status I-II.
• Women undergoing total abdominal hysterectomy (TAH) under spinal anesthesia.

Exclusion criteria

• History of allergies to local anesthetics.
• Local infection at the site of injection.
• Bleeding disorders.
• History of chronic use of analgesic.
• Physical or mental conditions.
• Hepatic, renal or cardiac disease.
• Contraindication to spinal anesthesia.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

60 participants in 2 patient groups

TFP group

Experimental group

Description:

Patients will receive spinal anesthesia (using 3.5 mL of hyperbaric bupivacaine 0.5%) with bilateral transversalis fascia plane (TFP) block (using 20 mL of bupivacaine 0.25%) at the end of surgery.

Treatment:

Other: Transversalis fascia plane block

IM group

Experimental group

Description:

Patients will receive spinal anesthesia (using 3 mL of hyperbaric bupivacaine 0.5%) + (75 µg morphine diluted in 0.5ml saline) with sham block at the end of surgery.

Treatment:

Drug: Morphine